Guggenheim Partners & Leerink Partners
6 shared events · Importance 3 · Last updated Aug 07, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Guggenheim Partners: Guggenheim Partners acted as a lead book-running manager, earning fees and demonstrating its capability in executing biotech IPOs. The successful offering supports its investment banking business.
Leerink Partners: Leerink Partners served as a lead book-running manager, generating underwriting revenue and reinforcing its expertise in healthcare IPOs. The deal enhances its reputation in the sector.
Aug 07, 2026 · 8 articles
Business
Guggenheim Partners: Guggenheim Partners is a joint book-running manager, participating in the offering and earning fees.
Leerink Partners: Leerink Partners is a joint book-running manager, participating in the offering and earning fees.
Aug 04, 2026 · 6 articles
Business
Guggenheim Partners: Guggenheim Partners is acting as a joint bookrunning manager for Neurogene's public offering.
Leerink Partners: Leerink Partners is acting as a joint bookrunning manager for Neurogene's public offering.
Jun 30, 2026 · 6 articles
Business
Guggenheim Partners: Guggenheim Partners is acting as an active book-running manager for the initial public offering of Parabilis Medicines.
Leerink Partners: Leerink Partners is acting as an active book-running manager for the initial public offering of Parabilis Medicines.
Jun 10, 2026 · 7 articles
Business
Guggenheim Partners: Guggenheim Partners acted as a joint book-running manager, earning underwriting fees.
Leerink Partners: Leerink Partners acted as a joint book-running manager for the IPO, earning fees and enhancing its reputation in biotech capital markets.
Jul 06, 2026 · 25 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Guggenheim Partners and Leerink Partners interact across events, view sentiment trends, and discover connected entities.
Open Dashboard